arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

BioScience Health Innovations, Inc.

BHIC

— Price unavailable

29 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

BioScience Health Innovations, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth -38.8% ↘

Op. Margin -30.6% ↘

ROIC -10.8% ↘

FCF / Share $-0.05

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

29-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$750.95K

↓ -38.8% —

Net Income Profit after all expenses

$-229.91K

↑ +1.6% —

Operating Margin Operating profit as % of sales

-30.6%

↓ -207.3% 62th

FCF / Share Free cash flow per share

$-0.05

↓ -56.5% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Feb 28, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Aug 31, 2021 10-K ↗	Q3 FY2021 Aug 31, 2021 10-Q ↗	Q2 FY2021 Aug 31, 2021 10-Q ↗	Q1 FY2021 Nov 30, 2021 10-Q ↗	Q4 FY2020 Aug 31, 2020 10-K ↗	Q3 FY2020 Aug 31, 2020 10-Q ↗	Q2 FY2020 Feb 29, 2020 10-Q ↗	Q1 FY2020 Nov 30, 2020 10-Q ↗	Q4 FY2019 Aug 31, 2019 10-K ↗	Q3 FY2019 Nov 30, 2019 10-Q ↗	Q2 FY2019 Nov 30, 2019 10-Q ↗	Q1 FY2019 Nov 30, 2019 10-Q ↗
Revenue Growth YoY (%)	-38.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-423%)	157.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1214%)	97.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+712%)	357.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2879%)	342.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2750%)	101.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+741%)	198.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1551%)	453.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3675%)	758.5% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6221%)	635.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5195%)	874.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7184%)	—	11490.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+95653%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	N/M	N/M	N/M	N/M	24.5% Good ↓ Good Declining Year-over-year change in net income	24.5% Good ↑ Good Improving Year-over-year change in net income	24.5% Good ↑ Good Improving Year-over-year change in net income	51.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-1579.3% Weak ↓ Weak Declining Year-over-year change in net income	-303.5% Weak ↑ Weak Improving Year-over-year change in net income	-1579.3% Weak ↓ Weak Declining Year-over-year change in net income	-1817.2% Weak ↓ Weak Declining Year-over-year change in net income	-31.2% Weak ↓ Weak Declining Year-over-year change in net income	-38.4% Weak ↓ Weak Declining Year-over-year change in net income	70.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-43.5% Weak ↑ Weak Improving Year-over-year change in net income	-66.6% Weak ↑ Weak Improving Year-over-year change in net income	-557.7% Weak Weak Year-over-year change in net income	-152.6% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	N/M	—	—	289.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	185.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	236.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	285.6% Excellent Excellent Compound annual revenue growth over 3 years	—	1538.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Feb 28, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Aug 31, 2021 10-K ↗	Q3 FY2021 Aug 31, 2021 10-Q ↗	Q2 FY2021 Aug 31, 2021 10-Q ↗	Q1 FY2021 Nov 30, 2021 10-Q ↗	Q4 FY2020 Aug 31, 2020 10-K ↗	Q3 FY2020 Aug 31, 2020 10-Q ↗	Q2 FY2020 Feb 29, 2020 10-Q ↗	Q1 FY2020 Nov 30, 2020 10-Q ↗	Q4 FY2019 Aug 31, 2019 10-K ↗	Q3 FY2019 Nov 30, 2019 10-Q ↗	Q2 FY2019 Nov 30, 2019 10-Q ↗	Q1 FY2019 Nov 30, 2019 10-Q ↗
Operating Margin (%) (%)	-30.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-253%)	-10.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-150%)	-0.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-104%)	26.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+30%)	34.8% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+74%)	1.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-92%)	9.8% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-51%)	19.3% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-19.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-196%)	-12.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-163%)	-29.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-249%)	-122.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-714%)	-218.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1193%)	-192.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1065%)	-429.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2247%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-30.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-304%)	-14.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-199%)	37.7% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+151%)	24.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+62%)	34.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+132%)	1.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-89%)	-9.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-162%)	-13.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-193%)	-19.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-228%)	-12.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-184%)	-36.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-345%)	-101.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-779%)	-218.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1558%)	-192.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1386%)	-21.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-242%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-73.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-6.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-30.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	16.2% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	26.8% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-8.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	18.0% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	-17.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-18.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-36.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-206.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-197.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-355.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-340.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	2.40x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.80x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-5.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	-1.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.47x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	16.65x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.71x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.92x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	2.39x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.21x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Feb 28, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Aug 31, 2021 10-K ↗	Q3 FY2021 Aug 31, 2021 10-Q ↗	Q2 FY2021 Aug 31, 2021 10-Q ↗	Q1 FY2021 Nov 30, 2021 10-Q ↗	Q4 FY2020 Aug 31, 2020 10-K ↗	Q3 FY2020 Aug 31, 2020 10-Q ↗	Q2 FY2020 Feb 29, 2020 10-Q ↗	Q1 FY2020 Nov 30, 2020 10-Q ↗	Q4 FY2019 Aug 31, 2019 10-K ↗	Q3 FY2019 Nov 30, 2019 10-Q ↗	Q2 FY2019 Nov 30, 2019 10-Q ↗	Q1 FY2019 Nov 30, 2019 10-Q ↗
Return on Invested Capital (%)	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	21.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	26.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	0.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	31.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	448.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-524.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	124.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	62.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	366.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	178.3% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	—	330.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	32.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	25.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	-17.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	-9.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	22.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	30.6% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	1.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	13.5% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	—	-34.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-135.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-258.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-252.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-65.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-50.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-14.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-13.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-13.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-15.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	24.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+35%)	24.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+34%)	33.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+83%)	1.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	-14.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-28.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-46.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-351%)	—	—	130.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+605%)	79.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+330%)	—	11.2% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	—	—	32.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+76%)	25.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+36%)	—	—	-22.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	-15.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	—	—	—	0.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Feb 28, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Aug 31, 2021 10-K ↗	Q3 FY2021 Aug 31, 2021 10-Q ↗	Q2 FY2021 Aug 31, 2021 10-Q ↗	Q1 FY2021 Nov 30, 2021 10-Q ↗	Q4 FY2020 Aug 31, 2020 10-K ↗	Q3 FY2020 Aug 31, 2020 10-Q ↗	Q2 FY2020 Feb 29, 2020 10-Q ↗	Q1 FY2020 Nov 30, 2020 10-Q ↗	Q4 FY2019 Aug 31, 2019 10-K ↗	Q3 FY2019 Nov 30, 2019 10-Q ↗	Q2 FY2019 Nov 30, 2019 10-Q ↗	Q1 FY2019 Nov 30, 2019 10-Q ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-31.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—
Net Debt (USD)	$-1.15M	$-661.92K	$-1.14M	$-1.30M	$-1.03M	$-662.52K	$-333.22K	—	$-92.94K	$-19.24K	—	$-30.32K	$-9.46K	$-11.57K	—	—	—	—	—	—	—	$-20.63K	$-20.63K	—	—	$0.00	$0.00	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Feb 28, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Aug 31, 2021 10-K ↗	Q3 FY2021 Aug 31, 2021 10-Q ↗	Q2 FY2021 Aug 31, 2021 10-Q ↗	Q1 FY2021 Nov 30, 2021 10-Q ↗	Q4 FY2020 Aug 31, 2020 10-K ↗	Q3 FY2020 Aug 31, 2020 10-Q ↗	Q2 FY2020 Feb 29, 2020 10-Q ↗	Q1 FY2020 Nov 30, 2020 10-Q ↗	Q4 FY2019 Aug 31, 2019 10-K ↗	Q3 FY2019 Nov 30, 2019 10-Q ↗	Q2 FY2019 Nov 30, 2019 10-Q ↗	Q1 FY2019 Nov 30, 2019 10-Q ↗
Revenue per Share (USD)	$0.07	—	$0.10	$0.04	$0.03	—	$0.01	$0.01	—	—	$0.00	—	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.02	$-0.02	$0.00	$0.01	$0.01	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.05	—	$-0.03	$0.01	$0.01	—	—	$0.00	—	—	$-0.00	—	—	—	—	$-0.01	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.15	$0.13	$0.16	$0.04	$0.03	$0.08	$0.01	$0.00	$0.00	$-0.00	$0.00	$-0.00	$-0.00	$-0.00	—	—	—	$-0.00	$-0.00	—	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—
Tangible Book Value per Share (USD)	$0.15	$0.13	$0.15	$0.04	$0.03	$0.07	$0.01	$0.00	$0.00	$-0.00	$0.00	$-0.00	$-0.00	$-0.00	—	—	—	$-0.00	$-0.00	—	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—
Basic Weighted Avg Shares (shares)	11.38M	—	10.98M	43.92M	43.92M	—	42.09M	41.60M	—	—	40.36M	—	—	—	—	5.46M	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Feb 28, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Aug 31, 2021 10-K ↗	Q3 FY2021 Aug 31, 2021 10-Q ↗	Q2 FY2021 Aug 31, 2021 10-Q ↗	Q1 FY2021 Nov 30, 2021 10-Q ↗	Q4 FY2020 Aug 31, 2020 10-K ↗	Q3 FY2020 Aug 31, 2020 10-Q ↗	Q2 FY2020 Feb 29, 2020 10-Q ↗	Q1 FY2020 Nov 30, 2020 10-Q ↗	Q4 FY2019 Aug 31, 2019 10-K ↗	Q3 FY2019 Nov 30, 2019 10-Q ↗	Q2 FY2019 Nov 30, 2019 10-Q ↗	Q1 FY2019 Nov 30, 2019 10-Q ↗
Total Equity (USD)	$1.68M	$1.48M	$1.71M	$1.72M	$1.26M	$835.24K	$370.28K	$189.08K	$114.86K	$-6.76K	$8.60K	$-54.25K	$-88.99K	$-17.18K	$-37.52K	—	$-1.01K	$-12.79K	$-12.79K	—	—	$12.82K	$12.82K	—	—	$0.00	$1.90K	—	—

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Feb 28, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Aug 31, 2021 10-K ↗	Q3 FY2021 Aug 31, 2021 10-Q ↗	Q2 FY2021 Aug 31, 2021 10-Q ↗	Q1 FY2021 Nov 30, 2021 10-Q ↗	Q4 FY2020 Aug 31, 2020 10-K ↗	Q3 FY2020 Aug 31, 2020 10-Q ↗	Q2 FY2020 Feb 29, 2020 10-Q ↗	Q1 FY2020 Nov 30, 2020 10-Q ↗	Q4 FY2019 Aug 31, 2019 10-K ↗	Q3 FY2019 Nov 30, 2019 10-Q ↗	Q2 FY2019 Nov 30, 2019 10-Q ↗	Q1 FY2019 Nov 30, 2019 10-Q ↗
Sales/Revenue/Turnover (USD)	$750.95K	$1.57M	$1.13M	$1.76M	$1.23M	$610.22K	$572.97K	$384.17K	$277.60K	$303.63K	$192.16K	$69.47K	$32.34K	$41.29K	$19.73K	$0.00	$279.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	$0.00
Net Income, GAAP (USD)	$-229.91K	$-233.63K	$426.80K	$426.80K	$426.80K	$9.96K	$-53.38K	$-53.38K	$-53.38K	$-38.38K	$-70.72K	$-70.72K	$-70.72K	$-79.66K	$-4.21K	$-17.53K	$-4.21K	$-4.16K	$-3.21K	$-12.67K	$-14.09K	$-2.90K	$-1.93K	$-1.93K	$-5.58K	—	$0.00	$0.00	$0.00
Operating Cash Flow (USD)	$-552.11K	$-100.70K	$-340.44K	$285.01K	$328.31K	$-50.30K	—	$69.30K	$-48.04K	$-56.46K	$-70.38K	—	$-66.67K	$-81.72K	$-70.13K	$-29.98K	$-949.00	$-7.98K	$-3.21K	$-12.35K	$-5.90K	$-2.90K	$-4.61K	$402.00	$-578.00	—	—	—	$-6.12K

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 29 quarters

BioScience Health Innovations, Inc.

Analytical Summary

29-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BHIC with peers